Krsnaa Diagnostics Limited IPO
Krsnaa Diagnostics Limited was a mainboard IPO in the Healthcare Service Provider sector, offered at ₹933–₹954 per share to raise ₹1,213 crore. The issue was subscribed 64.4× overall (QIBs 49.83×, NIIs 116.3×, retail 42.04×). It listed on 16 Aug 2021 at ₹1,006 and closed its first day at ₹987, a listing gain of +3.5% versus the ₹954 issue price. It now trades around ₹504 (-47.2% versus the issue price).
Frequently asked questions
- How many times was the Krsnaa Diagnostics Limited IPO subscribed?
- The Krsnaa Diagnostics Limited IPO was subscribed 64.4× overall — 49.83× in the QIB category, 116.3× among non-institutional investors, 42.04× in retail.
- What were the Krsnaa Diagnostics Limited IPO listing gains?
- Krsnaa Diagnostics Limited listed on 16 Aug 2021 at ₹1,006, closing its first day at ₹987 — a listing gain of +3.5% versus the ₹954 issue price.
- What were the retail allotment odds for the Krsnaa Diagnostics Limited IPO?
- Retail was subscribed 42.04×, so a single-lot application had roughly a 2.4% chance of allotment (about 1 in 42), and allotment was finalised on 10 Aug 2021.
- What was the price band and lot size of the Krsnaa Diagnostics Limited IPO?
- The price band was ₹933–₹954 per share, with a minimum lot of 15 shares (₹14,310 at the upper band).
- Who were the registrar and lead manager for the Krsnaa Diagnostics Limited IPO?
- KFin Technologies Private Limited was the registrar, and JM Financial was the book-running lead manager.